These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12843931)

  • 61. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nutrition in pathophysiology and treatment of nonalcoholic fatty liver disease.
    Moschen AR; Tilg H
    Curr Opin Clin Nutr Metab Care; 2008 Sep; 11(5):620-5. PubMed ID: 18685459
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
    Cuadrado A; Orive A; García-Suárez C; Domínguez A; Fernández-Escalante JC; Crespo J; Pons-Romero F
    Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Non-alcoholic steatohepatitis and metabolic syndrome.
    Machado M; Cortez-Pinto H
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C.
    Negro F; Clément S
    J Viral Hepat; 2009 Oct; 16(10):681-8. PubMed ID: 19732324
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nonalcoholic fatty liver disease.
    Adams LA; Angulo P; Lindor KD
    CMAJ; 2005 Mar; 172(7):899-905. PubMed ID: 15795412
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Definition and management of non-alcoholic steatohepatitis (NASH)].
    Hütteroth TH
    Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S64-7. PubMed ID: 11450617
    [No Abstract]   [Full Text] [Related]  

  • 68. [Non-alcoholic steatohepatitis].
    García Monzón C
    Gastroenterol Hepatol; 2001 Oct; 24(8):395-402. PubMed ID: 11674960
    [No Abstract]   [Full Text] [Related]  

  • 69. [Non-alcoholic steatohepatitis].
    Fehér J
    Orv Hetil; 2002 Aug; 143(32):1875-7. PubMed ID: 12221992
    [No Abstract]   [Full Text] [Related]  

  • 70. Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects.
    Ercin CN; Dogru T; Tasci I; Erdem G; Sonmez A
    Obes Surg; 2008 Oct; 18(10):1357; author reply 1358. PubMed ID: 18563498
    [No Abstract]   [Full Text] [Related]  

  • 71. [Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?].
    Miele L; Gabrieli ML; Forgione A; Vero V; Gallo A; Capristo E; Gasbarrini G; Grieco A
    Recenti Prog Med; 2006 Jan; 97(1):1-5. PubMed ID: 16535923
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Fatty liver. Classification, etiopathogenicity and clinical aspects].
    Kuntz E
    Munch Med Wochenschr; 1971 Nov; 113(46):1540-9. PubMed ID: 5171314
    [No Abstract]   [Full Text] [Related]  

  • 73. [Current knowledge of nonalcoholic steatohepatitis].
    Clemente Ricote G; García Monzón C
    Med Clin (Barc); 2003 Jun; 121(3):102-8. PubMed ID: 12855136
    [No Abstract]   [Full Text] [Related]  

  • 74. [Etiology and therapy of fatty liver].
    Thaler H
    Dtsch Med J; 1972 Nov; 23(11):648-53. PubMed ID: 4660035
    [No Abstract]   [Full Text] [Related]  

  • 75. [Percutaneous liver biopsy in a clinic for heart and vascular diseases].
    Weidemann R
    Med Klin; 1970 Apr; 65(14):656-61. PubMed ID: 5507798
    [No Abstract]   [Full Text] [Related]  

  • 76. Where does liver fat go? A possible molecular link between fatty liver and diabetes.
    Kikuchi A; Takamura T
    J Diabetes Investig; 2017 Mar; 8(2):152-154. PubMed ID: 27580368
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Non-alcoholic fatty liver disease].
    Wójcik K; Piekarska A
    Pol Arch Med Wewn; 2006 Feb; 115(2):172-81. PubMed ID: 17274475
    [No Abstract]   [Full Text] [Related]  

  • 78. Betaine: an old therapy for a new scourge.
    Neuschwander-Tetri BA
    Am J Gastroenterol; 2001 Sep; 96(9):2534-6. PubMed ID: 11569673
    [No Abstract]   [Full Text] [Related]  

  • 79. Iron, metabolic syndrome, nonalcoholic fatty liver disease and carotid atherosclerosis.
    Mascitelli L; Pezzetta F; Goldstein MR
    Atherosclerosis; 2009 Jul; 205(1):39-40. PubMed ID: 19155012
    [No Abstract]   [Full Text] [Related]  

  • 80. Nonalcoholic steatohepatitis clinical research network.
    Hepatology; 2003 Feb; 37(2):244. PubMed ID: 12540771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.